“…By using this approach, the individual NRPS (and other genes) could be engineered separately and then reintroduced into the expression hosts combinatorially. To accomplish this, (i) the A21978C and A54145 gene clusters were cloned in BAC vectors that could be engineered in Escherichia coli by λ-Red-mediated recombination; (ii) sets of mutants deleted for one or more A21978C and A54145 biosynthetic genes were generated; (iii) vectors were developed for genetic manipulation in E. coli , followed by conjugal transfer into S. roseosporus and S. fradiae expression hosts and site-specific integration into bacteriophage ϕC31 of ϕBT1 attB sites or into the IS 117 att site; (iv) engineered genes were expressed under the control of the strong, constitutive ermE * promoter; (v) fermentations were carried out, and novel compounds were confirmed by isolation and mass spectrometry and evaluated for microbiological activities. ,,,,,,− Reconstruction experiments confirmed that the NRPS genes could be expressed from the ermE* promoter at ectopic loci, giving lipopeptide yields comparable to controls. , This was significant because it demonstrated that constitutive expression of giant NRPS proteins during the early growth phase was not problematic, that the individual NRPS genes could be expressed from attB sites separated from the main NRPS clusters by multiple megabases, and that the NRPS multi-enzymes can assemble efficiently without sequencial translation from a single mRNA in a cellular subspace for antibiotic assembly.…”